Atlas Trials

D-Serine Monotherapy for Schizophrenia

Clinical trial NCT00215917 · UNKNOWN

Trial details

NCT number
NCT00215917
Sponsor
Herzog Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.